International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 8.13.2020
Global Myeloma Roundtable Guides Understanding of the COVID-19 Crisis
The IMF hosted a Global Roundtable of myeloma experts from Asia, the U.K., the U.S., and Europe this week in order to begin developing IMWG treatment recommendations for patients during the pandemic. Among the findings: a striking absence of cases of COVID-19 infections in myeloma patients in Asia. IMF Chairman Dr. Brian G.M. Durie shares important insights from the Roundtable discussions.
Register for a FREE IMF Patient & Family Webinar
The next IMF Patient & Family Webinar is scheduled for Saturday, August 15, at 1:00 p.m. PT / 4:00 p.m. ET. This FREE two-hour webinar will feature an introduction by Susie Durie, IMF President and CEO, followed by a discussion of the latest treatments for and management of myeloma. The panel, moderated by IMF Chairman Dr. Brian G.M. Durie, will include Dr. Joseph Mikhael of Translational Genomics Research Institute (TGen), Dr. Thomas Martin of the University of California San Francisco (UCSF) Health, and patient advocate Jack Aiello.
IMF Advocacy Reports on Executive Orders Impacting the Myeloma Community
In the last few weeks, President Trump has signed several executive orders that may have an impact on myeloma patients if the orders survive legal scrutiny. These orders address various topics, some of which include drug pricing and production, and rural access to care.
How to Give to a Race Without Racing: A Way to Remember a Loved One
Want to give to the Miracles for Myeloma 5K, but you are not a runner? It’s easy: simply make a donation and have a printable placard to be displayed on our Virtual Remembrance Path. Visit the virtual path here. Your placard will recognize a survivor, or honor a loved one who may have lost their battle but remains in our hearts. These signs will have the person’s name and your short note.
And This Too Shall Pass….
Once again, the IMF is hosting a raffle for a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. While many of us have been affected by COVID-19, we hope to remind you that this too shall pass. If you purchase the winning $50 raffle ticket, you could find yourself just minutes from the Hawaiian coastline. Note: Bookings will be in the future based on mutual availability with you and the property owner.
Learn About the Use of Teclistamab for Relapsed/Refractory Myeloma
In this video, Dr. Saad Z. Usmani (Levine Cancer Institute —Charlotte, North Carolina) explains the initial results from an ongoing study of teclistamab in relapsed/refractory multiple myeloma. Teclistamab (JNJ-64007957) is a bispecific BCMA (B-cell maturation antigen) plus CD3-antibody that induces T cell-mediated cytotoxicity against BCMA-expressing myeloma cells.
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

COVID-19 FAQ #20: What is a bubble? And should myeloma patients exercise this practice? 
Watch Now
Clinical Trials

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

Search the Myeloma Matrix 2.0

Smart Patients: Join the Conversation
Upcoming Events
Miracles for Myeloma
Virtual 5K Run/Walk/Bike

Watch a Replay
Post-ASCO / Post-EHA Webinar

Smile More Auction
Laughs 4 Life

Click here to see all events

We Thank Our Sponsors:

Amgen; Bristol-Myers Squibb; Genentech; GSK; Oncopeptides, Inc.; Sanofi-Genzyme; and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page